(Q33805000)

29 July 2017

1 reference

title

Call for a new approach to the process of clinical trials and drug registration (English)

1 reference

29 July 2017

T C Jones

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

29 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

The BMJ

1 reference

29 July 2017

volume

322

1 reference

29 July 2017

issue

7291

1 reference

29 July 2017

page(s)

920-923

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

A comparison of observational studies and randomized, controlled trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Uneasy alliance--clinical investigators and the pharmaceutical industry

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Adjunctive therapy for septic shock: a review of experimental approaches

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Recent developments in the design of phase II clinical trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Drug trials hide conflicts for doctors.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

The pharmaceutical industry--to whom is it accountable?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Is Academic Medicine for Sale?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

Ethical Issues Regarding Randomized, Placebo-Controlled Clinical Trials And Their Publication in Medical Journals

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1120078

The phase II/III transition. Toward the proof of efficacy in cancer clinical trials

30 October 2018

1 reference

12 December 2020

Prescription-event and other forms of epidemiological monitoring of side-effects in the UK

1 reference

12 December 2020

Congress, the FDA, and new drug development: before and after 1962

1 reference

12 December 2020

Incentives and Penalties in Health Care: Getting the Best from Pharmaceutical Development

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.322.7291.920

1 reference

29 July 2017

1 reference

29 July 2017

1 reference